Collectively, these findings identify cysteine addiction as a new liability in MYCN‐amplified neuroblastomas and propose to use ferroptosis‐inducing therapeutic strategies to treat MYCN‐driven neuroblastomas (Figure 1). The gene discussed is MYCN; the disease is neuroblastoma.